Novartis revenue and financials

NOVN · SIX · CHF

CHF 118.24Change from previous close: +0.90%Absolute change: +CHF 1.06

Close · October 7, 2026

In the fiscal year ended December 2025, Novartis reported revenue of $56.67B (+9.57% year over year). Net income was $13.98B, a net margin of 24.7%.

Annual revenue · 2025: $56.67B
  1. $43.97B2021
  2. $43.46B2022
  3. $46.66B2023
  4. $51.72B2024
  5. $56.67B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+9.57%
2025 vs 2024
Net income growth
+17.11%
2025 vs 2024
Net margin
24.7%
2024: 23.1%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Balance sheet · Annual
Item2025202420232022202120202019201820172017
Total assets110,949102,24699,945117,453131,795127,778118,370145,563133,075133,079
Current assets30,46029,70430,48136,91045,71829,67329,50435,563—28,208
Cash and equivalents11,43511,45913,3937,51712,4079,65811,11213,271—8,860
Short-term investments98.01,89268011,20915,817—————
Receivables10,8339,1319,2479,8019,563—————
Inventory6,2695,7235,9137,1756,666—————
Net property, plant and equipment12,35210,87310,92412,19513,106—————
Goodwill25,56724,75623,34129,30129,59529,99926,52435,294—31,750
Other intangible assets29,41126,91526,87931,64428,683—————
Long-term investments1,0911,1281,8271,6062,268—————
Current liabilities27,27828,69226,39028,65630,20833,05928,26429,60723,39623,403
Accounts payable4,4564,5724,9265,1465,553—————
Long-term debt28,72924,72220,62722,48525,52328,53122,35525,660—23,583
Total debt35,37631,25826,34827,909——————
Total liabilities64,40058,12053,19558,03063,97371,11262,81966,871—58,852
Total equity (incl. minority)46,54944,12646,75059,42367,822—————
Retained earnings44,72046,56149,64963,54070,989—————
Minority interest41980.083.081.0167—————